Celldex TherapeuticsCLDX 
$26.203.11%24h
3.11%24h
Global rank1947
Market cap$1.43B
Change 7d-1.43%
YTD Performance-33.30%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Celldex Therapeutics (CLDX) Stock Price History
As for today CLDX price is $26.20, a increase of 3.11% from yesterday.
The highest price of Celldex Therapeutics is $3375.00 on 2000-03-01. It's also known as the all time high (ATH) which refers to the highest price ever reached by a stock in its trading history.
The lowest price of Celldex Therapeutics is $1.50 on 2020-03-01. It's also known as the all time low (ATL) which refers to the lowest price ever reached by a stock in its trading history.
Stock Price History of Celldex Therapeutics from to 2024.
-
Value:-
Stock price history for Celldex Therapeutics by end of year
| Year | Price | Change |
|---|---|---|
| 2024 | $35.80 | -9.72% |
| 2023 | $39.66 | -11.02% |
| 2022 | $44.57 | 15.35% |
| 2021 | $38.64 | 120.55% |
| 2020 | $17.52 | 685.65% |
| 2019 | $2.23 | -25.67% |
| 2018 | $3.00 | -92.96% |
| 2017 | $42.60 | -19.77% |
| 2016 | $53.10 | -77.42% |
| 2015 | $235.20 | -14.08% |
| 2014 | $273.75 | -24.62% |
| 2013 | $363.15 | 260.80% |
| 2012 | $100.65 | 158.08% |
| 2011 | $39.00 | -36.89% |
| 2010 | $61.80 | -11.78% |
| 2009 | $70.05 | -41.04% |
| 2008 | $118.80 | 32.00% |
| 2007 | $90.00 | -62.69% |
| 2006 | $241.20 | -28.72% |
| 2005 | $338.40 | -6.47% |
| 2004 | $361.80 | -26.64% |
| 2003 | $493.20 | 142.48% |
| 2002 | $203.40 | -71.82% |
| 2001 | $721.80 | -41.67% |
| 2000 | $1.24K | 178.48% |
| 1999 | $444.38 | 41.07% |
| 1998 | $315.00 | -28.21% |
| 1997 | $438.75 | 50.00% |
| 1996 | $292.50 | -48.00% |
| 1995 | $562.50 | 25.00% |
| 1994 | $450.00 | -67.74% |
| 1993 | $1.40K | 5.08% |
| 1992 | $1.33K | -32.95% |
| 1991 | $1.98K | 274.47% |
| 1990 | $528.75 | -41.25% |
| 1989 | $900.00 | 150.00% |
| 1988 | $360.00 | -33.33% |
| 1987 | $540.00 | -11.11% |
| 1986 | $607.50 | - |
Price of Celldex Therapeutics compared to S&P500 (SPY/US500)
Celldex Therapeutics currently underperform the market.
View the most expensive stocks in the world.
